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1. Introduction 
Calcium binding protein (CaBP) is one of the 
known molecular expressions of the hormonal action 
of the calciferols (vitamin D) on intestine, especially 
in birds [1,2] and in rats [3,4]. CaBPs similar to or 
different from intestinal CaBP have been isolated from 
several tissues: brain [5], bone [6], kidney [7,8], 
uterus [9], parotid gland [lo], parathyroid glands 
[11,12],and placenta [13]. Some, but not all,ofthese 
CaBPs have been shown to be vitamin D-dependent, 
i.e., their amount, low or undetectable in D-deficient 
animals, increases significantly following vitamin D 
administration. 
The skin is a unique organ for the synthesis, storage, 
and release of vitamin D [ 14,151. The present study 
was undertaken in order to see whether CaBP is also 
present in this tissue. The results indicate that a 
vitamin D-dependent CaBP of a molecular weight 
(9000 + 2000) similar to that of rat intestinal CaBP 
(11 000 f ZOOO), but immunologically different from 
the latter, is present in rat skin. 
2. Materials and methods 
Male adult Sprangley albino rats (Charles River@, 
Elbeuf) -200 g, raised on a diet normal in calcium 
(0.7%) and in phosphorus (0.7%), containing 4 IU 
vitamin Ds/g diet were used. After removal of hair 
a skin sample (3 X 3 cm) from the dorsal region of 
each animal was taken under ether anesthesia. The 
skin samples were weighed, freezed by immersion 
into liquid nitrogen, minced (Moulinex type 302, 
Alencon) and homogenized in Tris buffer using a 
blender (homogeneiseur Baudard, Paris). The Tris 
buffer contained 1.37 X lo-* M Tris-HCl, 0.119 M 
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NaCl, 4.74 X 10m3 M KC1 (pH 7.4). Homogenization 
and all subsequent steps of extraction were carried 
out at 0-4°C. The homogenate was centrifuged for 
25 min at 3000 X g and the supernate was decanted. 
This low speed centrifugation was chosen in view 
of the possibility that the CaBP, if present in the skin, 
could be localized in cell membrane, in the cytosol, 
in mitochondria and/or in other intracellular organelles 
fractions as shown for chick and rat intestinal CaBP 
[3,16,17]. The supernate recovered after centrifuga- 
tion was lyophilized, redissolved in 4-5 ml elution 
buffer (0.02 M ammonium acetate 0.02% sodium azide 
(pH 7.4)) and chromatographed on a 2.5 X 85 cm 
Sephadex G-75 column. The flowrate was 35 drops/ 
min, and 5 ml fractions were collected. The fractions 
were analyzed for protein [ 181, and for calcium-bind- 
ing activity by the Chelex 100 competitive binding 
assay [19]. 
Further purification of the CaBP was obtained 
using DEAE-Sephadex A-25 ion exchange chromatog- 
raphy in a buffer containing 0.02 imidazole, 0.02 M 
NaCl, 1 mM EDTA (pH 7.2) as in [20,2 11, and a 
linear 0.20-0.70 M NaCl gradient. The proteins were 
subsequently desalted by application of the eluate to 
a Biogel P6 column equilibrated with ammonium 
acetate buffer. Void volume fractions were tested for 
calcium-binding activity. To check the purity of the 
protein obtained at each step of the procedure, poly, 
acrylamide gel electrophoresis was used according 
to [22] in the presence of 0.06 mM EDTA. 
Molecular weight of skin CaBP was estimated by 
means of the calibrated Sephadex G-75 column [17]. 
Measurements of CaBP were performed using an 
electroimmunodiffusion method. For this purpose 
antiserum to purified skin CaBP (anti-CaBP) was 
raised by injecting intradermally into several sites 
of the back of three 5 month white rabbits 150 pg 
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CaBP emulsified in Freund’s complete adjuvant. This 
initial dose was followed by a second injection after 
4 weeks. On day 49, blood was withdrawn by veinous 
puncture, the presence of anti-CaBP, its specificity 
and cross reactivity were tested using Outcherlony’s 
double immunodiffusion technique [23]. The anti- 
CaBP thus obtained was included in a buffered agarose 
solution (1% agarose, 0.02 ionic strength barbital 
buffer (pH 8.6)) at final cont. 8%. This solution was 
distributed as a uniform layer over a 5 X 10 cm glass 
plate. CaBP solutions (5 ~1) were placed in 2.5 mm 
diam. holes punched in the gel 0.5 cm from one short 
edge. Electrophoresis was carried out for 2 hat 200 V. 
Precipitin lines were made visible by staining with a 
1% solution of amide black 10 B [21]. The height of 
each ‘rocket’ was measured and used as an index of 
CaBP concentrations. A standard curve was obtained 
with purified skin CaBP. Appropriate dilutions in 
normal saline of the skin crude extract, obtained 
after homogenization and centrifugation, were used 
for the measurements of individual skin CaBP. With 
this technique the interassay variation is 3.4% and 
the detection limit 0.05 pug CaBP/mg protein. 
In an attempt to localize the cellular distribution 
of the skin CaBP the amount and the immunoreac- 
tivity of the protein obtained in the 3000 X g super- 
natant were compared to those of the protein 
obtained in a 100 000 X g supernatant. 
For the study of the vitamin D-dependence of 
skin CaBP male 21 day rats were fed a diet contain- 
ing no vitamin D and a normal (0.7%) or low content 
(0.02%) of calcium. After 4 weeks of this diet half 
of the animals were given by oral intubation 1 1.18 
vitamin DJday for 3 days. The amount of CaBP in 
each animal’s skin was measured and the result 
(mean ? SE) was compared to that observed in the 
vitamin D-deprived control group. The concentra- 
tion of calcium in serum was determined individually 
with the semiautomatic complexometric technique 
using a titrator (Marius Calcium Titrator, Amsterdam). 
Student’s r-test was used for statistical analysis. 
3. Results 
When a 3000 X g supernatant of rat skin homog- 
enate was chromatographed on Sephadex G-75 and 
the 4sCa-binding activity of the different fractions 
studied, 3 peaks were observed (fig.1): a chromato- 
graphic pattern similar to the one reported for intes- 
tinal extract [4,2 11. Peak 1 appeared at the void volume. 
Proteins of peak II showed the highest calcium-bind- 
ing activity, and the maximum activity appeared for 
an elution volume where VJV, = 2.0. On ion- 
exchange DEAE A-25 Sephadex column CaBP from 
peak II was eluted in the higher anionic form (EDTA 
1 mM) at 0.14 M NaCl; in the same system, rat intes- 
tinal CaBP elutes at 0.12 M NaCl (data not shown). 
10 30 50 70 90 fraction number 
Fig.1. Sephadex G-75 filtration of a 3000 X g supernatant of rat skin. Protein concentration (open circles) and calcium binding 
activity (closed circles) in the fractions eluted from Sephadex G-75 column. These results are those of the soluble heat-stable pro- 
teins from the 3000 X g supernatant of rat skin extract. 
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Fig.2. Acrylamide gel electrophoresis (pH 8.6) of aliquots of 
skin material from two stages of purification: (1) peak II 
(60 pg protein) from Sephadex gel filtration; (2) purified 
CaBP (20 pg protein) eluted from DEAE A25 chromatog- 
raphy. Samples were placed on the top of the gels and 
3 mA/tube were applied for 90 min. Migration was toward 
the anode (bottom) in presence of EDTA-Tris glycine 
buffer. The arrows indicate the localization of the tracking 
dye (bromophenol blue). 
Fig.2 shows the lectrophoretic pattern of the pooled 
fractions of skin CaBP (peak II) after Sephadex G-75, 
and the purification achieved after DEAE-Sephadex 
chromatography. The molecular weight of this puri- 
fied skin CaBP, estimated using a calibrated column is 
9000 + 2000, a value not different from the one found 
for rat intestinal CaBP, i.e., 11 000 f 2000 [17]. And 
the comparison of the staining pattern of purified 
intestinal and skin CaBPs showed the similarity of 
the anionic properties of both CaBPs in presence of 
EDTA (RF 0.80 and 0.84, respectively). 
The specificity of the rabbit antiserum was anal- 
yzed by double immunodiffusion [23]. The purity of 
the skin protein used to raise the antiserum was indi- 
cated by the presence of a single precipitin line when 
the skin extract was reacted against the antiserum 
(fig.3Al ,B4). No precipitation lines were obtained 
when the purified skin CaBP was incubated against 
non-immunized rabbit serum. Specificity of the rabbit 
antiserum to skin CaBP was shown by the total coales- 
cence of crude skin extract and purified skin CaBP 
(fig.3Al ,A2). Rat intestinal CaBP, purified from an 
aqueous extract obtained after a 100 000 X g centrifu- 
Fig.3. Ouchterlony double immunodiffusion: The center wells 
in A and B contain the antiserum to skin CaBP; (A) the 
outer well 1 contains the 3000 X g supernatant from skin 
extract, the outer well 2 the purified skin CaBP; (B) the 
outer well 1 contains purified skin CaBP, the one labeled 2 
purified intestinal CaBP, the wells marked 3 and 4 contain 
supernatant from crude extracts of intestinal mucosa and 
skin, respectively. 
gation, did not crossreact with the antiserum to skin 
CaBP (fig.3B2). Conversely, cross-immunoreactions 
could not be detected when rat intestinal antiserum 
was used against skin CaBP (data not shown). 
The immunoreactivity of the skin CaBP obtained 
from the fractionation of the 3000 X g supernatant 
and that obtained from the 100 000 X g supernatant 
were compared. The results showed that the 
100 000 X g supernatant CaBP reacted to the anti- 
serum in a manner identical to that of the 3000 X g 
supernatant. And, once again, no cross-immuno- 
reaction against rat intestinal CaBP antiserum could 
be detected neither with the 3000 X g supernatant 
nor with the 100 000 X g supernatant skin CaBP. 
The amount of CaBP present in the skin of normal 
rats, evaluated by electroimmunodiffusion assay [24] 
was found to be 27.1 f 2.2 pg/mg total protein. When 
the amounts of CaBP found in the 3000 X g super- 
natant, and in the 100 000 X g supernatant were com- 
pared, it appeared that the 100 000 X g supernatant 
contained 24.5 pg/mg protein, i.e., 90% of the 
amount found in the 3000 X g supernate. 
The effects of different dietary intakes of vitamin 
D and of calcium are shown in table 1. A diet of 
4 weeks without vitamin D induced in rats a signifi- 
cant decrease in serum calcium (8.0 + 0.3 versus 
10.3 + 0.1, p < 0.001). In these rats the amount of 
CaBP in the 3000 X g supernatant of skin decreased 
to 15.9 + 1.2 @ < 0.001). In rats fed a diet without 
vitamin D and low in calcium severe hypocalcemia 
was observed (5.5 f 0.1, p < 0.001). In this group a 
considerable amount of CaBP was still present in 
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Table 1 
Effects of vitamin D status and different dietary levels of 
calcium on skin CaBP 
Groups 
_ 
Expt I 
D+ Ca+ 
D- Ca+ 
Skin CaBP 
(Qg/mg protein) 
21.1 f 2.2 
(11) 
15.9 ? 1.2b 
(6) 
______ 
Serum calcium 
(mg/lOO ml) 
10.3 fr 0.1 
(9) 
8.0 + 0.3b 
(6) 
Expt II 
Dp Cap 
D+ Ca- 
34.1 + 3.1 5.5 f 0.1 
(8) (7) 
51.5 + 3.8a 7.1 * 0.2b 
(9) (9) 
__. 
Number in brackets indicates no. animals: ap < 0.01; 
bp < 0.001 
In expt I weanling rats were raised for 4 weeks on a diet 
normal in calcium and vitamin D (D+ Ca+ rats) or a diet 
normal in calcium and without vitamin D (D- Ca - rats). In 
expt II the weanling rats were raised on a diet containing 
0.02% of calcium and no vitamin D. After 4 weeks, the rats 
were given 1 pg vitamin D, orally (D+ Ca- rats) or its solvent 
(D- Ca- rats) for 3 days 
the skin (34.1 + 3.1 pg/mg total protein; table 1). 
However, when these rats were given vitamin D for 
3 days skin CaBP increased significantly (5 1.5 f 3.8 
pg/mg total protein, p < 0.01). This value is also 
significantly @ < 0.01) different from the value 
found in normal controls. 
4. Discussion 
This data shows that rat skin contains a protein 
with calcium-binding activity. The molecular weight 
of this CaBP (9000 + 2000) its ionic properties on 
ion-exchange chromatography, and its electrophoretic 
pattern in the presence of EDTA are similar to those 
of rat intestinal CaBP. Comparison of the amounts 
of skin CaBP obtained in a 3000 X g and in a 
100 000 X g supernatant seems to indicate that the 
cellular localization of this protein is mainly cytosolic. 
In spite of physical similarities no immunological 
similarity could be found between rat skin and intes- 
tinal CaBPs. Skin CaBP did not crossreact with anti- 
serum raised against intestinal CaBP. Conversely cross- 
reaction was not observed between intestinal CaBP 
and antiserum raised against skin CaBP. Clarification 
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of this difference in immunologic properties must await 
further studies on the amino acid sequence and con- 
formational characteristics of these two CaBPs. 
Another significant difference between rat skin and 
intestinal CaBPs is the apparent continued synthesis 
of the skin protein in the absence of dietary vitamin 
D. Nevertheless, the amount of CaBP in the skin of 
vitamin D-deficient rats is significantly lower indicat- 
ing that the CaBP activity detected in rat skin is 
indeed dependent on the vitamin D status. 
It is well documented that the level of intestinal 
vitamin D-dependent CaBP is regulated in an adapta- 
tive way to reflect the level of calcium present in 
the diet [17,26]. Our results would suggest hat 
this is also the case with skin CaBP since low dietary 
calcium prevents the decrease in CaBP level observed 
in the absence of vitamin D. However, when the 
vitamin D and calcium deprived rats are given vitamin 
D for 3 days the amount of skin CaBP increases 
significantly @ < 0.01) and reaches values higher 
than in the normal animals (table 1). This data would 
indicate that: 
6) 
(ii) 
Vitamin D, or more likely its active metabolite 
1,25-dihydroxyvitamin D, stimulates the syn- 
thesis of skin CaBP; 
As shown for intestine and bone CaBPs [17,26], 
the amount of CaBP in rat skin adapts inversely 
to the level of dietary calcium, most probably 
through changes in extra-cellular calcium concen- 
tration. 
As for the persistence of a decreased yet still con- 
siderable amount of CaBP in rat skin after 4 weeks of 
vitamin D deprivation this may be a reflection of the 
persistence of some vitamin D in these animals and/or 
of the slower cell turnover ate of skin [26,27] as 
compared to the intestinal mucosa. A greater esidence 
time of CaBP in chick kidney than in intestine has 
also been found and related to the slower cell turnover 
rate of kidney tissue [28,29]. 
The role of skin CaBP can not be elucidated here. 
However, the presence of a vitamin D-dependent CaBP 
in a tissue which is the unique site of endogenous 
vitamin D synthesis, may suggest a possible physio- 
logical role of this protein in vitamin D and/or calcium 
metabolism in the skin. 
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